Preliminary report
The platform is young, and the clinical infrastructure (CareGLP, named pharmacy partners, and LegitScript certification) checks out
"Obviously, we have the expansive platform, whether it's the oral medications that are already out there or if there is some reason that this patient would qualify for some level of personalization that exists
GLP-1 medications carry real risks including pancreatitis, thyroid concerns in predisposed individuals, and gastrointestinal side effects
On what amounted to a media tour across several months, including Oprah Winfreys podcast, she detailed how she lost about 15 kilograms in roughly a year
Semaglutide: From Diabetes Treatment to Weight Loss Breakthrough Semaglutide emerged in the mid-2010s as a long-acting GLP-1 agonist designed for once-weekly dosing in diabetes patients